{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:18:38Z","timestamp":1788347918409,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Hebei Natural Science Foundation","doi-asserted-by":"crossref","award":["H2024201041"],"award-info":[{"award-number":["H2024201041"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00044-026-03611-9","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:11:20Z","timestamp":1787285480000},"page":"1801-1818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis, biological activity and computational simulation evaluation of pyrimidine-2-aminoacetamide derivatives as cholinesterase inhibitors"],"prefix":"10.1007","volume":"35","author":[{"given":"Yi-Xuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"3611_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117201","volume":"284","author":"EA Fayed","year":"2025","unstructured":"Fayed EA, El-Sebaey SA, Ebrahim MA, Abu-Elfotuh K, El-Sayed Mansour R, Mohamed EK, et al. Discovery of novel bicyclic and tricyclic cyclohepta[b]thiophene derivatives as multipotent AChE and BuChE inhibitors, in-vivo and in-vitro assays, ADMET and molecular docking simulation. Eur J Med Chem. 2025;284:117201.","journal-title":"Eur J Med Chem"},{"key":"3611_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"MGMG Spillantini","year":"2006","unstructured":"Spillantini MGMG. A century of Alzheimer\u2019s disease. Science. 2006;314:777\u201381.","journal-title":"Science"},{"key":"3611_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105354","volume":"116","author":"S Manzoor","year":"2021","unstructured":"Manzoor S, Gabr MT, Rasool B, Pal K, Hoda N. Dual targeting of acetylcholinesterase and tau aggregation: design, synthesis and evaluation of multifunctional deoxyvasicinone analogues for Alzheimer\u2019s disease. Bioorganic Chem. 2021;116:105354.","journal-title":"Bioorganic Chem"},{"key":"3611_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/alz.038255","volume":"16","author":"L Chris","year":"2020","unstructured":"Chris L. World Alzheimer report 2019: attitudes to dementia, a global survey. Alzheimer\u2019s Dement. 2020;16:e038255.","journal-title":"Alzheimer\u2019s Dement"},{"key":"3611_CR5","doi-asserted-by":"publisher","first-page":"e12244","DOI":"10.1371\/journal.pone.0012244","volume":"5","author":"AD Smith","year":"2010","unstructured":"Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS one. 2010;5:e12244.","journal-title":"PLoS one"},{"key":"3611_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","volume":"44","author":"DM Walsh","year":"2004","unstructured":"Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease. Neuron. 2004;44:181\u201393.","journal-title":"Neuron"},{"key":"3611_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1567205014666170417111859","volume":"15","author":"Y Gao","year":"2018","unstructured":"Gao Y, Tan L, Yu J-T, Tan L. Tau in Alzheimer\u2019s disease: mechanisms and therapeutic strategies. Curr Alzheimer Res. 2018;15:283\u2013300.","journal-title":"Curr Alzheimer Res"},{"key":"3611_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114464","volume":"238","author":"Z Sang","year":"2022","unstructured":"Sang Z, Wang K, Dong J, Tang L. Alzheimer\u2019s disease: updated multi-targets therapeutics are in clinical and in progress. Eur J Med Chem. 2022;238:114464.","journal-title":"Eur J Med Chem"},{"key":"3611_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e39217","volume":"10","author":"L Peng","year":"2024","unstructured":"Peng L, Zhang Z, Li Q, Song Z, Yan C, Ling H. Unveiling the multifaceted pathogenesis and therapeutic drugs of Alzheimer\u2019s disease: a comprehensive review. Heliyon. 2024;10:e39217.","journal-title":"Heliyon"},{"key":"3611_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207\u201316.","journal-title":"Lancet Neurol"},{"key":"3611_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1021\/acs.jmedchem.0c01775","volume":"64","author":"E Viayna","year":"2020","unstructured":"Viayna E, Coquelle N, Cieslikiewicz-Bouet M, Cisternas P, Oliva CA, S\u00e1nchez-L\u00f3pez E, et al. Discovery of a potent dual inhibitor of acetylcholinesterase and butyrylcholinesterase with antioxidant activity that alleviates Alzheimer-like pathology in old APP\/PS1 mice. J Medicinal Chem. 2020;64:812\u201339.","journal-title":"J Medicinal Chem"},{"key":"3611_CR12","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1002\/alz.14174","volume":"20","author":"S Verdi","year":"2024","unstructured":"Verdi S, Rutherford S, Fraza C, Tosun D, Altmann A, Raket LL, et al. Personalizing progressive changes to brain structure in Alzheimer\u2019s disease using normative modeling. Alzheimer\u2019s Dement. 2024;20:6998\u20137012.","journal-title":"Alzheimer\u2019s Dement"},{"key":"3611_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116409","volume":"271","author":"DK Waiker","year":"2024","unstructured":"Waiker DK, Verma A, Gajendra TA, Namrata, Roy A, Kumar P, et al. Design, synthesis, and biological evaluation of some 2-(3 oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer\u2019s disease therapy. Eur J Med Chem. 2024;271:116409.","journal-title":"Eur J Med Chem"},{"key":"3611_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/jppr.1905","volume":"53","author":"MC Woodward","year":"2024","unstructured":"Woodward MC. Drug treatment of Alzheimer\u2019s disease: what has changed in 30\u2009years? J Pharm Pract Res. 2024;53:314\u20139.","journal-title":"J Pharm Pract Res"},{"key":"3611_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","volume":"139","author":"J Griffiths","year":"2023","unstructured":"Griffiths J, Grant SGN. Synapse pathology in Alzheimer\u2019s disease. Semin Cell Developmental Biol. 2023;139:13\u201323.","journal-title":"Semin Cell Developmental Biol"},{"key":"3611_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112350","volume":"198","author":"M Bortolami","year":"2020","unstructured":"Bortolami M, Pandolfi F, De Vita D, Carafa C, Messore A, Di Santo R, et al. New deferiprone derivatives as multi-functional cholinesterase inhibitors: design, synthesis and in vitro evaluation. Eur J Med Chem. 2020;198:112350.","journal-title":"Eur J Med Chem"},{"key":"3611_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.113124","volume":"212","author":"M Erdogan","year":"2021","unstructured":"Erdogan M, Kilic B, Sagkan RI, Aksakal F, Ercetin T, Gulcan HO, et al. Design, synthesis and biological evaluation of new benzoxazolone\/benzothiazolone derivatives as multi-target agents against Alzheimer\u2019s disease. Eur J Med Chem. 2021;212:113124.","journal-title":"Eur J Med Chem"},{"key":"3611_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114841","volume":"244","author":"X Li","year":"2022","unstructured":"Li X, Li T, Zhang P, Li X, Lu L, Sun Y, et al. Discovery of novel hybrids containing clioquinol-1-benzyl-1,2,3,6 tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer\u2019s disease. Eur J Med Chem. 2022;244:114841.","journal-title":"Eur J Med Chem"},{"key":"3611_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114806","volume":"244","author":"Y Wang","year":"2022","unstructured":"Wang Y, Xiong B, Lin H, Li Q, Yang H, Qiao Y, et al. Design, synthesis and evaluation of fused hybrids with acetylcholinesterase inhibiting and Nrf2 activating functions for Alzheimer\u2019s disease. Eur J Med Chem. 2022;244:114806.","journal-title":"Eur J Med Chem"},{"key":"3611_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114354","volume":"236","author":"AL Turcu","year":"2022","unstructured":"Turcu AL, Companys-Alemany J, Phillips MB, Patel DS, Gri\u00f1\u00e1n-Ferr\u00e9 C, Loza MI, et al. Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer\u2019s disease. Eur J Med Chem. 2022;236:114354.","journal-title":"Eur J Med Chem"},{"key":"3611_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115145","volume":"249","author":"K Bhanukiran","year":"2023","unstructured":"Bhanukiran K, TAG, Krishnamurthy S, Singh SK, Hemalatha S. Discovery of multi-target directed 3-OH pyrrolidine derivatives through a semisynthetic approach from alkaloid vasicine for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2023;249:115145.","journal-title":"Eur J Med Chem"},{"key":"3611_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.31083\/j.jin.2019.03.1105","volume":"18","author":"YPL Zhu","year":"2019","unstructured":"Zhu YPL, Hu J, Chen Y, Chen F. Current anti-Alzheimer\u2019s disease effect of natural products and their principal targets. J Integr Neurosci. 2019;18:327\u201339.","journal-title":"J Integr Neurosci"},{"key":"3611_CR23","doi-asserted-by":"publisher","first-page":"117925","DOI":"10.1016\/j.bmc.2024.117925","volume":"113","author":"P Gehlot","year":"2024","unstructured":"Gehlot P, Pathak R, Kumar S, Choudhary NK, Vyas VK. A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer\u2019s disease (AD). Bioorganic Medicinal Chem. 2024;113:117925.","journal-title":"Bioorganic Medicinal Chem"},{"key":"3611_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pneurobio.2018.12.006","volume":"174","author":"P Sharma","year":"2019","unstructured":"Sharma P, Srivastava P, Seth A, Tripathi PN, Banerjee AG, Shrivastava SK. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies. Prog Neurobiol. 2019;174:53\u201389.","journal-title":"Prog Neurobiol"},{"key":"3611_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115301","volume":"252","author":"F Pidany","year":"2023","unstructured":"Pidany F, Kroustkova J, Al Mamun A, Suchankova D, Brazzolotto X, Nachon F, et al. Highly selective butyrylcholinesterase inhibitors related to amaryllidaceae alkaloids - design, synthesis, and biological evaluation. Eur J Med Chem. 2023;252:115301.","journal-title":"Eur J Med Chem"},{"key":"3611_CR26","doi-asserted-by":"publisher","first-page":"130650","DOI":"10.1016\/j.bmcl.2026.130650","volume":"137","author":"YX Wang","year":"2026","unstructured":"Wang YX, Zhou XW, Du WR, Qin SH, Zhang CY, Ma ZY. Novel 2-aminopyrimidine carboxamide derivatives as potential anti-Alzheimer\u2019s disease agents: design, synthesis, biological activity and computational simulation evaluation. Bioorganic Medicinal Chem Lett. 2026;137:130650.","journal-title":"Bioorganic Medicinal Chem Lett"},{"key":"3611_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113973","volume":"227","author":"T Liu","year":"2022","unstructured":"Liu T, Chen S, Du J, Xing S, Li R, Li Z. Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5 yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2022;227:113973.","journal-title":"Eur J Med Chem"},{"key":"3611_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88\u201395.","journal-title":"Biochem Pharmacol"},{"key":"3611_CR29","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.3390\/pr11082248","volume":"11","author":"\u0130 Gulcin","year":"2023","unstructured":"Gulcin \u0130, Alwasel SH. DPPH radical scavenging assay. Processes. 2023;11:2248.","journal-title":"Processes"},{"key":"3611_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.fbp.2018.01.003","volume":"108","author":"T Wang","year":"2018","unstructured":"Wang T, Guo N, Wang SX, Kou P, Zhao CJ, Fu YJ. Ultrasound-negative pressure cavitation extraction of phenolic compounds from blueberry leaves and evaluation of its DPPH radical scavenging activity. Food Bioprod Process. 2018;108:69\u201380.","journal-title":"Food Bioprod Process"},{"key":"3611_CR31","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1039\/D6MD00165C","volume":"17","author":"B Kurban","year":"2026","unstructured":"Kurban B, Osmaniye D, Levent S, \u00d6zkay Y, Kaplanc\u0131kl\u0131 ZA. Quinoline\/thiazole compounds as selective acetylcholinesterase inhibitors: synthesis and biological assessment. RSC Medicinal Chem. 2026;17:2404\u201312.","journal-title":"RSC Medicinal Chem"},{"key":"3611_CR32","doi-asserted-by":"publisher","first-page":"17083","DOI":"10.1016\/S0021-9258(19)85305-X","volume":"268","author":"A Ordentlich","year":"1993","unstructured":"Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, et al. Dissection of the human acetylcholinesterase active center determinants of substrate specificity: identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J Biol Chem. 1993;268:17083\u201395.","journal-title":"J Biol Chem"},{"key":"3611_CR33","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.1678899","volume":"253","author":"JL Sussman","year":"1991","unstructured":"Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, et al. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science. 1991;253:872\u20139.","journal-title":"Science"},{"key":"3611_CR34","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1021\/bi962484a","volume":"36","author":"P Masson","year":"1997","unstructured":"Masson P, Legrand P, Bartels CF, Froment MT, Schopfer LM, Lockridge O. Role of aspartate 70 and tryptophan 82 in binding of succinyldithiocholine to human butyrylcholinesterase. Biochemistry. 1997;36:2266\u201377.","journal-title":"Biochemistry"},{"key":"3611_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114689","volume":"242","author":"W Liu","year":"2022","unstructured":"Liu W, Wu L, Liu W, Tian L, Chen H, Wu Z, et al. Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2022;242:114689.","journal-title":"Eur J Med Chem"},{"key":"3611_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113481","volume":"414","author":"R Cai","year":"2021","unstructured":"Cai R, Wang Y, Huang Z, Zou Q, Pu Y, Yu C, Cai Z. Role of RhoA\/ROCK signaling in Alzheimer\u2019s disease. Behavioural Brain Res. 2021;414:113481.","journal-title":"Behavioural Brain Res"},{"key":"3611_CR37","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/molecules22081287","volume":"22","author":"JK Lee","year":"2017","unstructured":"Lee JK, Kim NJ. Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer\u2019s disease. Molecules. 2017;22:1287.","journal-title":"Molecules"},{"key":"3611_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113874","volume":"226","author":"YH Li","year":"2021","unstructured":"Li YH, Sang SH, Ren WJ, et al. Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer\u2019s disease: a review (2010\u20132020). Eur J Med Chem. 2021;226:113874.","journal-title":"Eur J Med Chem"},{"key":"3611_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114444","volume":"238","author":"X Li","year":"2022","unstructured":"Li X, Han J, Bujaranipalli S, He J, Kim EY, Kim H, et al. Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2022;238:114444.","journal-title":"Eur J Med Chem"},{"key":"3611_CR40","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.drudis.2014.01.006","volume":"19","author":"I Yusof","year":"2014","unstructured":"Yusof I, Shah F, Hashimoto T, Segall MD, Greene N. Addressing toxicity risk when designing and selecting compounds in early drug discovery. Drug Discov Today. 2014;19:688\u201393.","journal-title":"Drug Discov Today"},{"key":"3611_CR41","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00044-021-02756-z","volume":"30","author":"Y Sicak","year":"2021","unstructured":"Sicak Y. Design and antiproliferative and antioxidant activities of furan-based thiosemicarbazides and 1,2,4-triazoles: their structure-activity relationship and SwissADME predictions. Med Chem Res. 2021;30:1557\u201368.","journal-title":"Med Chem Res"},{"key":"3611_CR42","first-page":"689","volume":"23","author":"JL Sussman","year":"2008","unstructured":"Sussman JL, Silman I. Acetylcholinesterases \u2013 the structural similarities and differences. J Enzyme Inhibition Med Chem. 2008;23:689\u2013703.","journal-title":"J Enzyme Inhibition Med Chem"},{"key":"3611_CR43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00204-010-0561-5","volume":"84","author":"P Masson","year":"2010","unstructured":"Masson P, Lockridge O. Structure, Activities and biomedical applications of human butyrylcholinesterase. Arch Toxicol. 2010;84:421\u201346.","journal-title":"Arch Toxicol"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03611-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03611-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03611-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:03:33Z","timestamp":1788347013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03611-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3611"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03611-9","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}